Effectiveness of Photodynamic Therapy in the Disinfection of Root Canals in Patients With Apical Lesion
NCT ID: NCT05916859
Last Updated: 2023-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
159 participants
INTERVENTIONAL
2023-04-01
2024-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Antimicrobial Photodynamic Therapy Associated With the Conventional Endodontic Treatment: A Clinical and Microbiological Study
NCT03212729
Photodynamic Therapy in Endodontic Treatment
NCT02824601
Estimate the Effect of aPDT on Root Canal Disinfection
NCT02929927
Clinical and Radiographic Evaluation of Photodynamic Therapy for Root Canal Treatment of Primary Molars
NCT05820750
The Effect of Antimicrobial Photodynamic Therapy on the Success of Root Canal Treatment
NCT06634745
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The patient sample will be randomized in 3 treatment groups: the first is the placebo group which will receive conventional endodontic treatment (ET) and a simulated treatment with the equipment in which no radiation will be emitted; the second group will receive conventional ET associated with PDT with diode laser at 660 nm, fluence 10 s/canal; and the third group will receive conventional ET associated with PDAT with laser at 660 nm, 20 s/canal. The photosensitizer used in the PDT will be methylene blue.
Clinical and radiographic examination of all the patients will be used to obtain baseline values (T0) and values 6 months post-treatment (T1). The presence and size of apical lesion will be assessed at T0 and T1, the percentage reduction of the lesion will be calculated and the PAI index will be used as a scoring system to assess the lesion. The success rate will be assessed for each group 6 months after completion of the treatment. Disinfection of the root canals will be assessed by analysis of colony formation (ufc/ml); biological samples will be taken with paper cones inserted into the root canals to the apical region at two moments: Baseline (before treatment, T0); after instrumentation with PDT (experimental groups) and without PDT (placebo group). Adverse events will be analysed; a serious adverse event for this study is any unfavourable odontological event that the investigators believe to bear a causal relation with the experimental intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1. Placebo
routine endodontic treatment will be applied and the application of laser will be simulated with the equipment, but no radiation will be emitted
Group 1. Placebo
Conventional endodontic treatment
Group 2. PDT 10 s
Conventional ET + PDT. PDT will be carried out with diode laser with optical fibre coupled to the equipment (660 nm, 100 mW, 10 s). The photosensitizer used will be methylene blue.
Group 2 PDT (10 s)
\- Conventional endodontic treatment associated with PDT (10 s)
Group 3: PDT 20 s
Conventional ET + PDAT. PDAT will be carried out with diode laser with optical fibre coupled to the equipment (660 nm, 100 mW, 20 s). The photosensitizer used will be methylene blue.
Group 3 PDT 20 s
Conventional endodontic treatment associated with PDAT (20 s)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group 2 PDT (10 s)
\- Conventional endodontic treatment associated with PDT (10 s)
Group 3 PDT 20 s
Conventional endodontic treatment associated with PDAT (20 s)
Group 1. Placebo
Conventional endodontic treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Adult patients of either sex
2. No general biological risk
3. At least 1 molar with pulp necrosis and apical lesion
Exclusion Criteria
2. Patients requiring complex dental rehabilitation due to major coronal destruction
3. Individuals with cognitive disability making conventional treatment impossible
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de La Frontera
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Naira Figueiredo Deana
Máster
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nilton Alves, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidad de La Frontera
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad San Sebastián
Santiago, , Chile
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hector Monardes
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Alves N, Deana NF, Abarca J, Monardes H, Betancourt P, Zaror C. Root Canal Disinfection in Permanent Molars with Apical Lesion by Antimicrobial Photodynamic Therapy: Protocol for a Blind Randomized Clinical Trial. Photobiomodul Photomed Laser Surg. 2024 May;42(5):366-374. doi: 10.1089/photob.2023.0186.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DI21-0033
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
Folio N°062/21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.